This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Warszawski Uniwersytet Medyczny, Instytut Farmaceutyczny, Siec Badawcza Lukasiewicz-Instytut Chemii Przemyslowej Imienia Profesora Ignacego Moscickiego. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Plock, PL (2015)
- Pruszków, PL (2019)
- Pruszkow, PL (2022)
Company Filing History:
2 out of 12 
1 out of 10 
1 out of 1 Years Active: 2015-2022
Title: The Innovative Journey of Kamil Jatczak
Introduction
Kamil Jatczak, an accomplished inventor based in Pruszków, Poland, has made significant contributions to the field of pharmaceuticals. With two patents to his name, he focuses on compounds with pharmacological properties, particularly those related to vascular health.
Latest Patents
Jatczak's most recent patents include innovations surrounding protoescigenin derivatives. The first patent describes a compound that includes a protoescigenin derivative known for its pharmacological effects. This invention outlines not only the preparation process of the compound but also its application as a medicament, especially in treating vascular disorders. The second patent emphasizes a method for obtaining protoescigenin through a dual-step hydrolysis process involving both acidic and basic conditions. This process allows for the enrichment and isolation of protoescigenin in a high-purity crystalline form, which can serve as a building block for further chemical modifications of naturally occurring saponins.
Career Highlights
Throughout his career, Kamil Jatczak has collaborated with esteemed institutions, contributing to the advancement of pharmaceutical research. He has worked at the Medical University of Warsaw and the Pharmaceutical Institute, where his research and innovations have gained recognition in the scientific community.
Collaborations
Jatczak's collaborative efforts are noteworthy, especially with colleagues such as Oliwia Zegrocka-Stendel and Grzegorz Grynkiewicz. These partnerships reflect his commitment to advancing pharmaceutical sciences through teamwork and shared expertise.
Conclusion
Kamil Jatczak represents a remarkable example of innovation in the field of pharmacology. With his focus on protoescigenin derivatives and their applications, he continues to contribute to the medical sciences, showcasing the importance of research and collaboration in driving forward the boundaries of healthcare solutions. His patents highlight his significant role as an inventor and his dedication to improving treatments for vascular disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile